Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19

Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections

Long, Q.-X., Tang, X.-J., Shi, Q.-L., Li, Q., Deng, H.-J., Yuan, J., Hu, J.-L., Xu, W., Zhang, Y., Lv, F.-J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0965-6 · Cited by 2,686

SARS‐CoV‐2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup

Stadlbauer, D., Amanat, F., Chromikova, V., Jiang, K., Strohmeier, S., Arunkumar, G. A., Tan, J., Bhavsar, D., Capuano, C., Roubidoux, E. K., et al. (2020) · Current Protocols in Microbiology · doi:10.1002/cpmc.100 · Cited by 635

Disappearance of Antibodies to SARS-Associated Coronavirus after Recovery

Cao, W.-C., Liu, W., Zhang, P.-H., Zhang, F., & Richardus, J. H. (2007) · New England Journal of Medicine · doi:10.1056/nejmc070348 · Cited by 367

Living on Three Time Scales: The Dynamics of Plasma Cell and Antibody Populations Illustrated for Hepatitis A Virus

Andraud, M., Lejeune, O., Musoro, J. Z., Ogunjimi, B., Beutels, P., & Hens, N. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002418 · Cited by 75

Longitudinal Analysis of Severe Acute Respiratory Syndrome (SARS) Coronavirus-Specific Antibody in SARS Patients

Chang, S., Wang, J., Huang, L., Chen, Y., Fang, C., Sheng, W., Wang, J., Yu, C., & Yang, P. (2005) · Clinical and Vaccine Immunology · doi:10.1128/cdli.12.12.1455-1457.2005 · Cited by 32

Approaching the Interpretation of Discordances in SARS-CoV-2 Testing

Wontakal, S. N., Bortz, R. H., Lin, W.-H. W., Gendlina, I., Fox, A. S., Hod, E. A., Chandran, K., Prystowsky, M. B., Weiss, L. M., & Spitalnik, S. L. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab144 · Cited by 2

Durable tracking anti-SARS-CoV-2 antibodies in cancer patients recovered from COVID-19

Huang, Y., Yu, J., Li, D., He, K., Liu, W., Wang, L., Chen, Y., Xie, C., & Wu, X. (2021) · Scientific Reports · doi:10.1038/s41598-021-96195-w · Cited by 2

SECCION II. Definiciones operativas de casos de infección por SARS-CoV-2/COVID-19

Trujillo, C. H. S. (2021) · Infectio · doi:10.22354/in.v25i4.972 · Cited by 2

Evaluation of 2 commercial anti-SARS-CoV-2 antibody assays in an immunocompetent and immunocompromised inpatient population with COVID-19

Harrington, D., Azim, T., Rosmarin, C., Cutiño‐Moguel, T., & Hopkins, M. J. (2021) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2021.115449 · Cited by 2

SARS-CoV-2 mechanisms of action and impact on human organism, risk factors and potential treatments. An exhaustive survey

Carro, B. (2021) · All Life · doi:10.1080/26895293.2021.1977186 · Cited by 2

Blunted Post-COVID-19 Humoral Immunity in Patients With CNS Demyelinating Disorders on Anti-CD20 Treatments

Money, K. M., Baber, U., Saart, E., Samaan, S., & Sloane, J. A. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.843081 · Cited by 2

Longitudinal T Cell Responses against Ancestral, Delta, and Omicron SARS-CoV-2 Variants Determined by Rapid Cytokine Release Assay in Whole Blood

Oliver, M. A., Meredith, R. T., Smith, B. R., Bermingham, M. D., Brackett, N. F., & Chapman, M. D. (2022) · ImmunoHorizons · doi:10.4049/immunohorizons.2200044 · Cited by 2

Analysis of a German blood donor cohort reveals a high number of undetected SARS-CoV-2 infections and sex-specific differences in humoral immune response

Fischer, B., Knabbe, C., & Vollmer, T. (2022) · PLoS ONE · doi:10.1371/journal.pone.0279195 · Cited by 2

Trends of participants in convalescent plasma donation for COVID-19 in Japan as the pandemic evolved

Suzuki, T., Asai, Y., Takahashi, K., Sanada, M., Shimanishi, Y., Terada, M., Sato, L., Inada, M., Yamada, G., Akiyama, Y., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e20568 · Cited by 2

Application of Interferon-γ Release Assay in the Assessment of T-Cell Immunity to SARS-CoV-2 Antigens in the Cohort of Pediatric Patients with Juvenile Idiopathic Arthritis

Kapten, K., Orczyk, K., & Smolewska, E. B. (2024) · Children · doi:10.3390/children11060736 · Cited by 2

Return to work strategy with antibody-based tests in COVID19: An observational study from a metropolitan area, India

Chawla, N., Ray, S., Gupta, A., Maramraj, K. K., Kumar, S. S., & Anand, K. (2020) · Journal of Marine Medical Society · doi:10.4103/jmms.jmms_90_20 · Cited by 2

Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) IgG results among healthcare workers in a rural upstate New York hospital system

Brunner, W. M., Hirabayashi, L., Krupa, N. L., Scribani, M., Jenkins, P., Clark, S. D., May, J. J., & Gadomski, A. (2020) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2020.1296 · Cited by 2

Eastern Cape Healthcare Workers Acquisition of SARS-CoV-2 (ECHAS): Cross-Sectional (Nested Cohort) Study Protocol

Adeniyi, O. V., Stead, D., Singata‐Madliki, M., Batting, J. R., Hyera, L., Jelliman, E., Abrahams, S., & Parrish, A. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18010323 · Cited by 2

A Comprehensive Review of Possible Immune Responses against Novel SARS-CoV-2 Coronavirus: Vaccines Strategies and Challenges

Shahriar, A., Mahmud, A. R., Ahmed, H. M., Rahman, N., & Khatun, M. C. (2021) · Austin Journal of Microbiology · doi:10.26420/austinjmicrobiol.2021.1028 · Cited by 2

Seroprevalence of Anti-SARS-CoV-2 Antibodies Three Months Post Infection in Healthcare Professionals at an Oncology Hospital in Northern Portugal

Silva, D. F. E., Silva, P. D., Torgal, A., Braga, S., Rocha, D., Ochoa, C., Oliveira, Á. M., Rocha, L., Dias, J. M., & Baldaque, I. (2021) · Acta Médica Portuguesa · doi:10.20344/amp.16336 · Cited by 2

Persistent Antibody Responses to SARS-CoV-2 Infection in Cancer Patients: A Single-Center Retrospective Observational Study

Agarwal, A., Baghmar, S., Qureshi, S. R., Khurana, A., Setia, R., Khan, M. A., Barman, P., Kapoor, R. K., Hasthavaram, N. R., Kumar, R., et al. (2021) · Indian Journal of Medical and Paediatric Oncology · doi:10.1055/s-0041-1733823 · Cited by 2

Persistence of infection-induced SARS-CoV-2 seropositivity throughout gestation

Staszewski, C. L., Rochelson, B. L., Krantz, D., Gerber, R. P., Juhel, H., Reddy, S., & Blitz, M. J. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.09.037 · Cited by 2

First Identification of Reinfection by a Genetically Different Variant of SARS‐CoV‐2 in a Homeless Person from the Metropolitan Area of Santiago, Chile

Acuña‐Castillo, C., Vidal, M., Inostroza-Molina, A., Vallejos‐Vidal, E., Luraschi, R., Figueroa, M., Barrera‐Avalos, C., Vera, R., Vargas, S., Valdés, D., et al. (2022) · Journal of Environmental and Public Health · doi:10.1155/2022/3859071 · Cited by 2

Manufacturer Signal-to-Cutoff Threshold Underestimates Cumulative Incidence of SARS-CoV-2 Infection: Evidence from the Los Angeles Firefighters Study

Toubat, O., Berg, A. H., Sobhani, K., Mulligan, K., Hori, A. M., Bhattacharya, J., & Sood, N. (2022) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfac034 · Cited by 2

COVID-19 Outbreaks and Age Mortality PatternsPreprint

Shapiro, V. (2020) · Research Square · doi:10.21203/rs.3.rs-113791/v1 · Cited by 2

Impact of Prior Infection on Protection and Transmission of SARS-CoV-2 in Golden HamstersPreprint

Zhang, C., Guo, Z., Li, N., Cui, H. Y., Meng, K., Liu, L., Zhao, L., Zhang, S., Qin, C., Liu, J., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.30.428920 · Cited by 2

Regarding: Masyeni S, Santoso MS, Widyaningsih PD, Wedha Asmara DG, Nainu F, Harapan H, et al. Serological cross-reaction and co-infection of dengue and COVID-19 in Asia: Experience from Indonesia. Int J Infect Dis 2020;102:152–4. https://doi.org/10.1016/j.ijid.2020.10.043

Biswas, S., Sukla, S., Roy, S., Nath, H., & Mallick, A. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.01.063 · Cited by 2

Knowledge, Attitude, and Practice among the Healthcare Professionals regarding the myths on COVID-19 vaccination - DemystifiedPreprint

Lokesh Kumar, S., Naik, Z., Panwar, A., Sridhar, M. R., Keluskar, V. K., & Kumar, R. S. (2021) · medRxiv · doi:10.1101/2021.07.30.21261378 · Cited by 2

Retrospective Diagnosis of SARS-CoV-2 Infection in Patients with Long COVID by Measuring Specific T Cell Mediated IL-2 ReleasePreprint

Krishna, B. A., Lim, E. Y., Mactavous, L., NIHR BioResource Team, Lyons, P., Döffinger, R., Bradley, J. R., Smith, K. G. C., Sinclair, J. H., Matheson, N. J., et al. (2021) · SSRN Electronic Journal · doi:10.21203/rs.3.rs-989434/v1 · Cited by 2

Prior SARS-CoV-2 Infection Prevents Acute Disease and Lung Pathology in Reinfected Syrian Hamsters but not Virus Replication in the Upper Respiratory TractPreprint

Hansen, F., Meade-White, K. D., Clancy, C. S., Okumura, A., Hawman, D. W., Feldmann, F., Kaza, B., Jarvis, M. A., Rosenke, K., & Feldmann, H. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3929650 · Cited by 2

NSAIDs/Nitazoxanide/Azithromycin Immunomodulatory Protocol Used in Adults, Children and Pregnant COVID-19 Patients: An Egyptian Prospective Observational Study.Preprint

Kelleni, M. T. (2021) · doi:10.31219/osf.io/k8z5u · Cited by 2

Stockholm Syndrome: How to come to peace with our captor

Grant, J., Schwartz, I. S., & Laupland, K. B. (2020) · Journal of the Association of Medical Microbiology and Infectious Disease Canada · doi:10.3138/jammi-2020-10-07 · Cited by 1

The Effect of Antibodies in the Presence of Syncytia During Viral Infections

Beach, I., & Dobrovolny, H. M. (2025) · Bulletin of Mathematical Biology · doi:10.1007/s11538-025-01463-9 · Cited by 1

The dynamic assessment of immune status in children after a new coronavirus infection

Москалева, Е. В., Петрова, А. Г., Rychkova, L. V., Novikova, E. A., Kozlova, I. V., & Kolesnikova, L. I. (2025) · Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук · doi:10.29413/abs.2025-10.2.17 · Cited by 1

Mathematical modeling of the effect of multiple vaccines on viral escape

Mohan, T., & Dobrovolny, H. M. (2025) · Mathematics and Computers in Simulation · doi:10.1016/j.matcom.2025.09.010 · Cited by 2

Factors influencing SARS-CoV-2 IgG test sensitivity: A Bayesian analysis of seroconversion and seroreversion by time since infection, test, age and disease severity

Braeye, T., Abrams, S., & Hens, N. (2026) · PLoS ONE · doi:10.1371/journal.pone.0328144 · Cited by 1

SECCION I. Antecedentes de infección por SARS-CoV-2/COVID-19

Trujillo, C. H. S. (2021) · Infectio · doi:10.22354/in.v25i4.971 · Cited by 1

Virological Correlates of IgM–IgG Patterns of Response to SARS-CoV-2 Infection According to Targeted Antigens

Barreiro, P., Candel, F. J., Sanz, J. C., Román, J. S., Carretero, M. D. M., Pérez-Abeledo, M., Ramos, B., Viñuela-Prieto, J. M., Canora, J., Martínez-Peromingo, F. J., et al. (2021) · Viruses · doi:10.3390/v13050874 · Cited by 1

Immune Response to COVID-19

Alberca, R. W. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.98964 · Cited by 1

Prevalence of SARS-CoV-2 antibodies and risk factors in the pandemic epicentre of Catalonia

Moreno, S., Catalina, Q. M., Soler, A., Gallego, M., Homs, M., & Garcia, M. J. (2022) · Scientific Reports · doi:10.1038/s41598-022-13290-2 · Cited by 1

Exploring the Potential of Non-Pharmacological Therapeutic Interventions to Promote Resilience of the Human Immune System. Part I: Biological Foundations and Structured Exercise

Parker, C. (2022) · OALib · doi:10.4236/oalib.1108691 · Cited by 1

Anti-SARS-CoV-2 antibody responses in convalescent plasma donors with varying severity of COVID-19 illness

Grujić, J., Bujandrić, N., Budakov-Obradović, Z., Savic, N., & Dolinaj, V. (2022) · Vojnosanitetski pregled · doi:10.2298/vsp210301094g · Cited by 1

A Tutorial on Common Differential Equations and Solutions Useful for Modeling Epidemics Like COVID-19: Linear and Non-Linear Compartmentation Models

Mulkern, R. V., & Nosrati, R. (2022) · Journal of Applied Mathematics and Physics · doi:10.4236/jamp.2022.1010204 · Cited by 1

Temporal pattern of humoral immune response in mild cases of COVID-19

Campos, I. M. P., Marques, M., Peiter, G. C., Brandalize, A. P. C., dos Santos, M. B., de Melo, F. F., & Teixeira, K. N. (2023) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v14.i2.40 · Cited by 1

Creation of collective immune as the main preventive measure for the spread of the new coronavirus infection (COVID-19)

Тоvanova, A. (2022) · Vestnik of Saint Petersburg University Medicine · doi:10.21638/spbu11.2022.306 · Cited by 4

The essential elements of adaptive immunity and their relevance to cancer immunology

Bullock, T. N. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-87763-3.00016-2 · Cited by 1

Immunological survey of COVID-19 among medicos of tribal preponderant state of India

Kumari, S., Jeseena, K., Kiran, A. K., Kujur, M., Saroj, U., Hembrom, S. S., & Kujur, A. (2023) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_272_23 · Cited by 1

Comparison of different T cell assays for the retrospective determination of SARS-CoV-2 infection

Krishna, B. A., Metaxaki, M., Perera, M. R., Wills, M. R., & Sithole, N. (2024) · Journal of General Virology · doi:10.1099/jgv.0.002055 · Cited by 1

Reconstructing the first COVID-19 pandemic wave with minimal data in England

Chen, S., Flegg, J. A., Lythgoe, K., & White, L. J. (2025) · Epidemics · doi:10.1016/j.epidem.2025.100814 · Cited by 1

The Impact of COVID-19 on Dental Clinic Transmission: Leveraging Internet of Things Technology

Uygun-Can, B., Durmazpınar, P. M., Hati̇poğlu, Ş., Bolat, B. A., Özen, Ç., Öveçoğlu, H. S., & Kadir, T. (2025) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s499841 · Cited by 1

Convalescent plasma for the treatment of patients with COVID-19: the Singapore experience and lessons learnt

Tay, J. Y., Sadasiv, M. S., Fan, B. E., Fong, S. Z., Boo, C. K., Ding, Y., Chia, W., Tan, C. W., Young, B. E., Lim, P. L., et al. (2025) · Singapore Medical Journal · doi:10.4103/singaporemedj.smj-2024-089 · Cited by 1

Adjuvant-dependent protection of SARS-CoV-2 spike vaccines: comparative immunogenicity of human-applicable formulations

Pan, Z., Jiang, L., Chen, Y., Peng, H., Liu, Y., Zheng, X., He, Y., Liu, Y., Wang, Y., Zhang, X., et al. (2025) · Journal of Virology · doi:10.1128/jvi.01099-25 · Cited by 1

Schrödinger’s Worker: Are They Positive or Negative for SARS-CoV-2?

Meloni, F., Campagna, M., Restivo, A., & Cocco, P. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17176316 · Cited by 1

Antibodies to SARS-CoV2 detectable for less than 50 days in polymerase chain reaction confirmed COVID-19 patients

Kumar, N. G., Bhartiya, S., & Singh, T. (2020) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20203893 · Cited by 1

Cribado de SARS-CoV-2 de pacientes en hemodiálisis crónica en un hospital de tercer nivel y sus centros periféricos: una hora menos en Canarias

Valga, F., Monzón, T., Vega-Díaz, N., Antón-Pérez, G., & Rodríguez-Pérez, J. C. (2020) · Nefrología · doi:10.1016/j.nefro.2020.08.004 · Cited by 1

Interacciones entre SARS-CoV-2 y el sistema de defensas del aparato respiratorio: consideraciones para la prevención y el manejo de las infecciones

Cruz, J. R. (2020) · Ciencia Tecnologí­a y Salud · doi:10.36829/63cts.v7i3.974 · Cited by 1

Laboratory correlates of SARS-CoV-2 seropositivity in a nationwide sample of patients on dialysis in the U.S.

Anand, S., Montez‐Rath, M. E., Han, J., García, P., Bozeman, J., KERSCHMANN, R. L., Beyer, P., Parsonnet, J., & Chertow, G. M. (2021) · PLoS ONE · doi:10.1371/journal.pone.0249466 · Cited by 1

COVID-19 Reinfection and its Diagnostic Approach

William, A., & Kaur, R. (2021) · American Journal of Applied Sciences · doi:10.3844/ajassp.2021.71.78

Serosurveillance of Anti SARS-Cov-2 Antibodies among Essential Workers in Navi Mumbai - A Single Centre Study

Maheshwari, U. M., Sahai, J., & Hebbar, V. (2021) · International Journal of Health Sciences and Research · doi:10.52403/ijhsr.20210714 · Cited by 1

A practical approach to SARS-CoV-2 testing in a pre and post-vaccination era

Taylor, S. C. (2021) · Journal of Clinical Virology Plus · doi:10.1016/j.jcvp.2021.100044 · Cited by 1

Seroprevalence of COVID-19 IgG Antibody in Resident and Fellow Physicians in Milwaukee, Wisconsin: Analysis of a Cross-Sectional Survey

Baumgardner, D. J., Schwank, A., Kram, J. J. F., Lehmann, W., Bidwell, J., Fratta, T. L., & Copeland, K. (2022) · Journal of patient-centered research and reviews · doi:10.17294/2330-0698.1846 · Cited by 1

SARS-CoV-2 IgG Seroprevalence Detected by Chemiluminescence Immunoassay Among Healthcare Personnel and Patients in a Province With a Low Incidence Rate of COVID-19 During the First Wave of COVID-19 in Thailand

Patamatamkul, S., Rawangban, P., Prommongkol, B., & Potongcamphan, M. (2022) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0000000000001150 · Cited by 1

Reinfection by SARS CoV2 in Valle Del Cauca, Colombia: A Descriptive Retrospective Study

Hurtado, I. C., Hurtado, J. S., Valencia, S. L., Pinzón, E. M., Guzmán, A. R., & Lesmes, M. C. (2022) · INQUIRY The Journal of Health Care Organization Provision and Financing · doi:10.1177/00469580221096528 · Cited by 1

Anti-viral memory T cell responses in the absence of IgG production in a COVID-19 convalescent individual

Ni, L., Ye, F., Qiao, Q., Yu, F., Yang, Y., Zhao, H. J., Zhang, L.-N., Cheng, M., Zhu, G., Li, X., et al. (2022) · National Science Open · doi:10.1360/nso/20220009 · Cited by 1

Concordance of SARS-CoV-2 Antibody Results during a Period of Low Prevalence

Miller, C. N., Althoff, K. N., Schlueter, D. J., Anton‐Culver, H., Chen, Q., Garbett, S. P., Ratsimbazafy, F., Thomsen, I. P., Karlson, E. W., Cicek, M. S., et al. (2022) · mSphere · doi:10.1128/msphere.00257-22 · Cited by 1

SARS-CoV-2 spike IgG titres up to 137 days following Comirnaty mRNA COVID-19 vaccination, Israel, February to May 2021

Patalon, T., Moshe, S. B., Peretz, A., Neuberger, A., Schreiber, L., Lazar, R., Supino‐Rosin, L., Perez, G., Mizrahi-Reuveni, M., & Gazit, S. (2022) · Eurosurveillance · doi:10.2807/1560-7917.es.2022.27.40.2100703 · Cited by 1

SUPPLEMENT 12 SEEC & 32 IMAB, Section Medicine

(2023) · Journal of IMAB - Annual Proceeding (Scientific Papers) · doi:10.5272/jimab.2022supplement1 · Cited by 1

Longitudinal SARS-CoV-2 serosurveillance of over ten thousand health care workers in the Providence Oregon cohortPreprint

Leidner, R. S., Frary, A., Cramer, J., Ball, D., Weerasinghe, R. K., Schmidt, M., Jin, J. B., Luzzi, V. I., Saitman, A., Young, J. A., et al. (2020) · medRxiv · doi:10.1101/2020.08.16.20176107 · Cited by 1

Prime-boost protein subunit vaccines against SARS-CoV-2 are highly immunogenic in mice and macaquesPreprint

Tan, H., Juno, J. A., Lee, W. S., Barber-Axthelm, I. M., Kelly, H. G., Wragg, K. M., Esterbauer, R., Amarasena, T. H., Mordant, F. L., Subbarao, K., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.01.278630 · Cited by 1

Using COVID-19 deaths as a surrogate to measure the progression of the pandemicsPreprint

Hernández-Suárez, C., & Murillo‐Zamora, E. (2020) · medRxiv · doi:10.1101/2020.09.27.20202564 · Cited by 1

Updating Herd Immunity Models for the U.S. in 2020: Implications for the COVID-19 ResponsePreprint

Sheils, N. E., Lyng, G. D., & Berke, E. M. (2020) · medRxiv · doi:10.1101/2020.10.05.20207100 · Cited by 1

The Road Less Traveled: SARS-CoV-2 and Cell-Mediated Immunity

Morris, K. V. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.10.003 · Cited by 1

COVID-19 PANDEMICS: HOW FAR ARE WE FROM HERD IMMUNITY?Preprint

Hernández-Suárez, C., Murillo‐Zamora, E., & Espinoza‐Gómez, F. (2020) · medRxiv · doi:10.1101/2020.12.19.20248571 · Cited by 1

Unexplained longitudinal variability in COVID-19 antibody status by Lateral Flow Immuno-Antibody testingPreprint

Davis, K. A. S., Oetzmann, C., Carr, E., Lavelle, G., Leightley, D., Malim, M. H., Vitiello, V., Wickersham, A., KCL-CHECK team, Razavi, R., et al. (2021) · medRxiv · doi:10.1101/2021.08.23.21261638 · Cited by 1

SARS-COV-2 Neutralizing Activity in Serum Collected from Recovered and Vaccinated Health Care WorkersPreprint

Mouna, L., Razazian, M., Duquesne, S., Roque-Afonso, R.-A., & Vauloup‐Fellous, C. (2021) · Research Square · doi:10.21203/rs.3.rs-951588/v1 · Cited by 1

Spike-specific CXCR3 + T FH cells play a dominant functional role in supporting antibody responses in SARS-CoV-2 infection and vaccinationPreprint

Zhang, J., He, R., Liu, B., Zheng, X., Wu, Q., Wen, B., Wang, Q., Liu, Z., Chang, F., Hu, Y., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.09.503302 · Cited by 1

Accounting for assay performance when estimating the temporal dynamics in SARS-CoV-2 seroprevalence in the U.SPreprint

García‐Carreras, B., Hitchings, M. D. T., Johansson, M. A., Biggerstaff, M., Slayton, R. B., Healy, J. M., Lessler, J., Quandelacy, T. M., Salje, H., Huang, A. T., et al. (2022) · medRxiv · doi:10.1101/2022.09.13.22279702 · Cited by 1

Correction of immune status from hospitalized COVID-19-patients with immunotropic drug added to the basic treatment

Khromova, E. A., Костинов, М. П., Skhodova, S. A., Osiptsov, V. N., Bisheva, I. V., Пахомов, Д. В., Kurbatova, E. A., Альбертовна, Х. А., Kryukova, N. O., & Николаевич, Ш. М. (2023) · Medical Immunology (Russia) · doi:10.15789/1563-0625-coi-2852 · Cited by 1

SARS-CoV-2 Seroprevalence in Relation to Timing of SymptomsPreprint

Ebinger, J. E., Botwin, G. J., Albert, C. M., Alotaibi, M., Arditi, M., Berg, A. H., Binek, A., Botting, P. G., Fert‐Bober, J., Figueiredo, J. C., et al. (2020) · medRxiv · doi:10.1101/2020.08.02.20166876

Thoughts From the Trenches: Should We Look at the “Healthy”?

Martínez-Taboada, V. M., López‐Hoyos, M., Crespo, J., Muñoz, P., & Hernández, J. L. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00490

Covid-19: is there an end in sight

Nc, B. (2020) · International Journal of Health Research and Medico Legal Practice · doi:10.31741/ijhrmlp.v6.i2.2020.1

SARS-CoV-2 e a Importância do Diálogo entre Clínicos e o Laboratório

Franco-Leandro, P. (2020) · Acta Médica Portuguesa · doi:10.20344/amp.14954

Upcoming SARS-CoV-2 vaccine: expectations and reality

Mohapatra, P. R., & Mishra, B. (2020) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2020-138821

Can Cancer Survivors Donate Convalescent Plasma for the Treatment of COVID-19?

Venniyoor, A. (2021) · Indian Journal of Medical and Paediatric Oncology · doi:10.1055/s-0041-1729734

COVID-19: Balancing between Transmission Suppression and Immunity

Lee, D. (2020) · Clinical Ultrasound · doi:10.18525/cu.2020.5.2.35

A Novel Model for Simulating COVID-19 Dynamics Through Layered Infection States that Integrate Concepts from Epidemiology, Biophysics and Medicine: SEI 3 R 2 S-NrecPreprint

Winters, J. M. (2020) · medRxiv · doi:10.1101/2020.12.01.20242263

Diclofenac potassium/nitazoxanide/azithromycin novel COVID-19 protocol used in adults, children and pregnant patients: could it be the magic bullet?Preprint

Kelleni, M. T. (2020) · doi:10.22541/au.160797486.63735316/v1

LABORATORY TESTING AND SCREENING FOR SARS-CoV-2: A REVIEW OF CURRENT METHODS

Marjanović, D., Primorac, D., Matišić, V., Perić, V., Molnar, V., & Zadro, R. (2020) · Genetics & Applications · doi:10.31383/ga.vol4iss2pp1-9

Do COVID-19 Antibodies Provide Long-Term Protection?

Ansari, S. F., Memon, M. A., Kumar, R., Memon, S., & Memon, M. K. (2021) · Cureus · doi:10.7759/cureus.12441

A Case of Prolonged Shedding of SARS-Cov-2 with Rapid Decay of IgG AntibodyPreprint

Huang, J., Lan, C., Huang, M., & Wang, X.-H. (2021) · Research Square · doi:10.21203/rs.3.rs-151695/v1

The Frequency of SARS-CoV-2 Specific Memory B Cells in COVID-19 Recovered Patients Remain Stable While Antibodies Decay Over TimePreprint

Vaisman‐Mentesh, A., Dror, Y., Maimon, L., Kigel, A., Rosenstein, S., Eyran, T., Bahar, Y., Taussig, D. C., Tur‐Kaspa, R., Kournos, T., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3751788

The kinetic variations of anti-nucleocapsid antibody in SARS-CoV-2 infectionPreprint

Kawada, S., Ogata, A., Kato, Y., Okamoto, M., Yamaguchi, Y., Morita, T., & Kumanogoh, A. (2021) · medRxiv · doi:10.1101/2021.02.05.21251208

A importância da resposta imune celular na Covid-19

Napimoga, M. H., & Pinho, A. J., Jr. (2021) · InterAmerican Journal of Medicine and Health · doi:10.31005/iajmh.v4i.185

Severe Acute Respiratory Syndrome Coronavirus 2 Episode 2? A Sequel Nobody Wants to See

Piantadosi, A. L. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab224

SARS-CoV-2 Reinfection within the first 3 months of COVID-19 Recovery in A Referral Hospital, Tehran, IranPreprint

Sadr, S., Bafrani, M. A., Abdollahi, A., SeyedAlinaghi, S., Mohammadnejad, E., Hossienzade, R., Golestan, F. S., Ahmadinejad, Z., Salehi, M., Javaherian, M., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-271345/v1

La incógnita del coronavirus – Parte III

Romero, J. P. (2020) · Revista Peruana de Ginecología y Obstetricia · doi:10.31403/rpgo.v66i2297

COVID-19: No Guaranteed Protection from Future Infection after the Initial Diagnosis

Chew, C., & Mannepalli, S. (2021) · Case Reports in Infectious Diseases · doi:10.1155/2021/6617719

COVID-19 Outbreaks and Age Mortality PatternsPreprint

Shapiro, V. (2020) · Research Square · doi:10.21203/rs.3.rs-113791/v2

Assessment of anti SARS-CoV-2 antibodies present in convalescent plasma donors aimed at being used in COVID-19 treatment

Constantin, S., CEBOTARI, S., Sajin, O., Spînu, I., Donos, A., Ana, V., Gostev, I., & DOPIRA, I. (2021) · One Health & Risk Management · doi:10.38045/ohrm.2021.2.08

Late Reinfection With a Different SARS-CoV-2 Clade in a Patient With Refractory Arterial Hypertension: a Case Report.Preprint

Galiana, A., García‐Abellán, J., Fernández‐González, M., Gonzalo-Jiménez, N., Ruiz‐García, M., Galera, M. A., Vega, S. F., Masiá, M., & Gutiérrez, F. (2021) · Research Square · doi:10.21203/rs.3.rs-392287/v1

Long-term and short-term immunity to SARS-CoV-2: why it matters

Zaunders, J., & Phetsouphanh, C. (2021) · Microbiology Australia · doi:10.1071/ma21010

Minimally reduced levels of anti-Spike IgG after nine COVID-19 convalescent plasma donations: a case report

Wasiluk, T., Rybinska, K., Rogowska, A., Boczkowska‐Radziwon, B., & Radziwon, P. (2021) · Medical Research Journal · doi:10.5603/mrj.a2021.0017

Guide pratique à l’intention des laboratoires cliniques pour les tests de sérologie du SRAS-CoV-2

(RLSPC), A. N. D. G. D. T. S. L. S. D. R. D. L. D. S. P. D. C., Charlton, C. L., Kanj, J., Tran, V., Kus, J. V., Gubbay, J. B., Osiowy, C., Robinson, J. L., Sekirov, I., DREBOT, M. A., et al. (2021) · Relevé des maladies transmissibles au Canada · doi:10.14745/ccdr.v47i04a01f

Diagnostic performance of serological test, antibody response and correlation with clinical characteristics in health workers with COVID-19 from the General Hospital of Luque

López, E., Duarte, J., Grijalba, R., González, A., Cuenca, E., Enciso, A., Ríos, E., Galeano, M., Sánchez, S., González, L., et al. (2021) · Revista de salud publica del Paraguay · doi:10.18004/rspp.2021.junio.8 · Cited by 1

Longitudinal observation of antibody responses after SARS-CoV-2 infection at 14 monthsPreprint

Zaidi, A., Dehgani-Mobaraki, P., Yadav, N., & Floridi, A. (2021) · Research Square · doi:10.21203/rs.3.rs-618366/v1

Loss of Anti–SARS-CoV-2 Antibodies in Mild Covid-19

Bölke, E., Matuschek, C., & Fischer, J. C. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2027051 · Cited by 95

Rapid decline of neutralizing antibodies is associated with decay of IgM in adults recovered from mild COVID-19

Harrington, W. E., Trakhimets, O., Andrade, D. V., Dambrauskas, N., Raappana, A., Jiang, Y., Houck, J., Selman, W., Yang, A., Vigdorovich, V. I., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100253 · Cited by 65

Neutralizing Antibodies Against SARS-CoV-2—Important Questions, Unclear Answers

Katz, M. H. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.4624 · Cited by 6

Longitudinal anti-SARS-CoV-2 antibody profile and neutralization activity of a COVID-19 patient

Yin, S., Tong, X., Huang, A., Shen, H., Li, Y., Liu, Y., Wu, C., Huang, R., & Chen, Y. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.06.076 · Cited by 26

Longitudinal analysis of antibody decay in convalescent COVID-19 patients

Xia, W., Li, M., Wang, Y., Kazis, L. E., Berlo, K., Melikechi, N., & Chiklis, G. R. (2021) · Scientific Reports · doi:10.1038/s41598-021-96171-4 · Cited by 32